UY23825A1 - Procedimiento para la preparación de derivados de pirido [1,2,3-d,e] [1,3,4] benzoxadiazina.- - Google Patents

Procedimiento para la preparación de derivados de pirido [1,2,3-d,e] [1,3,4] benzoxadiazina.-

Info

Publication number
UY23825A1
UY23825A1 UY23825A UY23825A UY23825A1 UY 23825 A1 UY23825 A1 UY 23825A1 UY 23825 A UY23825 A UY 23825A UY 23825 A UY23825 A UY 23825A UY 23825 A1 UY23825 A1 UY 23825A1
Authority
UY
Uruguay
Prior art keywords
benzoxadiazine
preparation
compounds
pyrid
derivatives
Prior art date
Application number
UY23825A
Other languages
English (en)
Spanish (es)
Inventor
Thomas Jaetsch Dr
Burkhard Mielke Dr
Uwe Petersen Dr
Thomas Phillipps Dr
Thomas Schenke Dr
Klaus Dieter Bremm Dr
Rainer Endermann Dr
Karl Georg Metzger Dr
Martin Scheer Dr
Michael Stegemann Dr
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of UY23825A1 publication Critical patent/UY23825A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
UY23825A 1993-09-02 1994-09-02 Procedimiento para la preparación de derivados de pirido [1,2,3-d,e] [1,3,4] benzoxadiazina.- UY23825A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4329600A DE4329600A1 (de) 1993-09-02 1993-09-02 Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate

Publications (1)

Publication Number Publication Date
UY23825A1 true UY23825A1 (es) 1995-02-24

Family

ID=6496640

Family Applications (1)

Application Number Title Priority Date Filing Date
UY23825A UY23825A1 (es) 1993-09-02 1994-09-02 Procedimiento para la preparación de derivados de pirido [1,2,3-d,e] [1,3,4] benzoxadiazina.-

Country Status (31)

Country Link
US (1) US5508278A (enExample)
EP (1) EP0647644B1 (enExample)
JP (1) JPH0782272A (enExample)
KR (1) KR100342034B1 (enExample)
CN (1) CN1041731C (enExample)
AT (1) ATE159944T1 (enExample)
AU (1) AU687833B2 (enExample)
CA (1) CA2131103C (enExample)
CZ (1) CZ211394A3 (enExample)
DE (2) DE4329600A1 (enExample)
DK (1) DK0647644T3 (enExample)
EG (1) EG20425A (enExample)
ES (1) ES2108348T3 (enExample)
FI (1) FI943999A7 (enExample)
GR (1) GR3025740T3 (enExample)
HR (1) HRP940470B1 (enExample)
HU (1) HUT71098A (enExample)
IL (1) IL110828A (enExample)
JO (1) JO1799B1 (enExample)
MY (1) MY131768A (enExample)
NO (1) NO943239L (enExample)
NZ (1) NZ264334A (enExample)
PH (1) PH31003A (enExample)
PL (1) PL177249B1 (enExample)
RU (1) RU2131430C1 (enExample)
SI (1) SI0647644T1 (enExample)
SK (1) SK101994A3 (enExample)
SV (1) SV1994000041A (enExample)
TW (1) TW304196B (enExample)
UY (1) UY23825A1 (enExample)
ZA (1) ZA946700B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4416622A1 (de) * 1994-05-11 1995-11-16 Bayer Ag 8-Amino-10-(azabicycloalkyl)-pyrido[1,2,3-d.e] [1,3,4]benzoxa-diazinderivate
DE4427530A1 (de) * 1994-08-04 1996-02-08 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE4435479A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
KR100411620B1 (ko) * 1995-12-29 2004-03-18 고려화학 주식회사 Pvc프레임용불소도료조성물
DE19652239A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
FR2928150A1 (fr) 2008-02-29 2009-09-04 Vetoquinol Sa Sa Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
EP2145891A1 (en) * 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0635458B2 (ja) * 1985-02-15 1994-05-11 大日本製薬株式会社 ピリドンカルボン酸誘導体、そのエステルおよびその塩
DE3788177D1 (de) * 1986-09-12 1993-12-23 Hoffmann La Roche Pyrido [3,2,1-ij]-1,3,4-benzoxadiazinderivate, Verfahren zu deren Herstellung, entsprechende pharmazeutische Präparate und im Verfahren verwendbare Zwischenprodukte.
US4864023A (en) * 1986-09-12 1989-09-05 Hoffmann-La Roche Inc. Pyrido(3,2,1-IJ)-1,3,4-benzoxadiazine derivatives
US5591744A (en) * 1987-04-16 1997-01-07 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
GB9010941D0 (en) * 1990-05-16 1990-07-04 Erba Carlo Spa Delta 2-cephem sulphones
DE4032560A1 (de) * 1990-10-13 1992-04-16 Bayer Ag 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate
CA2076982A1 (en) * 1990-12-27 1992-06-28 Akira Okura Pyridonecarboxylic acid derivatives
DE4120646A1 (de) * 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
TW209865B (enExample) * 1992-01-10 1993-07-21 Bayer Ag
NO304832B1 (no) * 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
CN1053907C (zh) * 1993-01-23 2000-06-28 辉瑞大药厂 生产三环化合物的方法

Also Published As

Publication number Publication date
CA2131103C (en) 2006-06-13
PH31003A (en) 1997-12-23
US5508278A (en) 1996-04-16
CN1041731C (zh) 1999-01-20
FI943999A7 (fi) 1995-03-03
CN1106014A (zh) 1995-08-02
SV1994000041A (es) 1995-05-26
SI0647644T1 (en) 1998-04-30
NO943239L (no) 1995-03-03
PL177249B1 (pl) 1999-10-29
RU2131430C1 (ru) 1999-06-10
HU9402523D0 (en) 1994-10-28
AU687833B2 (en) 1998-03-05
KR950008515A (ko) 1995-04-17
CA2131103A1 (en) 1995-03-03
EP0647644B1 (de) 1997-11-05
NO943239D0 (no) 1994-09-01
RU94031745A (ru) 1996-08-10
DK0647644T3 (da) 1998-07-27
SK101994A3 (sk) 1995-05-10
KR100342034B1 (ko) 2002-11-13
AU7148594A (en) 1995-03-16
HUT71098A (en) 1995-11-28
HRP940470B1 (en) 1998-12-31
MY131768A (en) 2007-08-30
CZ211394A3 (en) 1995-03-15
TW304196B (enExample) 1997-05-01
EG20425A (en) 1999-04-29
IL110828A0 (en) 1994-11-11
ZA946700B (en) 1995-05-02
IL110828A (en) 1997-04-15
JPH0782272A (ja) 1995-03-28
FI943999A0 (fi) 1994-08-31
DE4329600A1 (de) 1995-03-09
ES2108348T3 (es) 1997-12-16
PL304877A1 (en) 1995-03-06
ATE159944T1 (de) 1997-11-15
NZ264334A (en) 1995-03-28
JO1799B1 (en) 1994-12-25
GR3025740T3 (en) 1998-03-31
DE59404525D1 (de) 1997-12-11
HRP940470A2 (en) 1996-10-31
EP0647644A1 (de) 1995-04-12

Similar Documents

Publication Publication Date Title
MX9304649A (es) Procedimiento para producir 7-(sustituido)-9-[glicilo sustituido]-6-desmetil-6-desoxitetraciclinas.
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
PT86770A (pt) Process for preparing benzophenone derivatives
ES2086346T3 (es) Derivados de acido quinoloncarboxilico, procedimiento para su fabricacion asi como su uso como agentes antiviricos.
MA19996A1 (fr) Procede de preparation de derives disubstitues de la proline
PT83423B (en) Process for preparation of new quinoline derivatives
ES470269A1 (es) Procedimiento para la preparacion de nuevos derivados de benzodiazepinona
ES2079391T3 (es) Procedimiento para la obtencion de 2,7-diazabiciclo(3.3.0)octanos.
ES2031509T3 (es) Un procedimiento para la preparacion de agentes antiarritmicos.
ES519650A0 (es) Un procedimiento para obtener derivados de indanilbenzamida.
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
MX156436A (es) Procedimiento para preparar derivados de 7-(pirrol-1-il) de los acidos -1-etil-1, 4-dihidro -4-oxoquinolein-3-carboxilico y 1-etil-1, 4-dihdro -4-oxo-(1,8-naftiridin)-3-carboxilico substituidos
AR228041A1 (es) Procedimiento para producir compuestos de pirazolo(3,4-b)(1,5)benzodiazepina
BR9911250A (pt) Processo para preparação de compostos
AR010260A1 (es) Compuestos derivados de 1-(2-metoxifenil)-4-(fenoxialquilen)-piperazina; composiciones farmaceuticas que los contienen; un proceso para la preparacionde dichos compuestos y composiciones farmaceuticas y uso de dicho compuestos
ES2061532T3 (es) Derivados sustituidos de acido piridina-2,4-dicarboxilico, procedimientos para su preparacion, utilizacion de los mismos, asi como medicamentos a base de estos compuestos.
EG13590A (en) Process for the production of trans-5-aryl-2,3,4,4a,5,9b-hexahydro-th-pyrido(4,3-b)indoles of use as tranquilizing agents
ES8401962A1 (es) Un procedimiento para la preparacion de un derivado de piridoindol.
PT73841A (en) Process for preparing novel guanidine derivatives
ES8504792A1 (es) Un procedimiento para preparar derivados de pirimidina
ES2082890T3 (es) Procedimiento para la preparacion de derivados 6-(aminopropionilo sustituido) de forskolina.
ES462643A1 (es) Procedimiento para la preparacion de compuestos antraquini- nicos.
CU22751A3 (es) Derivados de ácido quinolon- y naftiridoncarboxílico
DK152499C (da) Analogifremgangsmaade til fremstilling af 2-amino-8-cyclopropyl-5-oxo-5,8-dihydro-pyridooe2,3-daapyrimidin-6-carboxylsyrer
ES2053590T3 (es) 3-fenil-7h-tiazolo(3,2-b)(1,2,4)triazin-7-onas sustituidas, procedimiento para su preparacion, medicamentos que las contienen y su empleo, asi como algunos productos intermedios formados durante la preparacion de los compuestos mencionados.

Legal Events

Date Code Title Description
VENC Patent expired

Effective date: 20140301